跳至主要内容
临床试验/IRCT20230511058153N1
IRCT20230511058153N1招募中3 期

Comparison of the combined effect of mesalazine-crocin with mesalazine alone in the treatment of inflammatory bowel disease

Shahre-kord University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Inflammatory bowel diseases including Crohn's or ulcerative colitis
  • Informed consent to participate in the study
  • No history of other autoimmune diseases
  • No history of underlying diseases
  • No use of other medicinal plants
  • Patients with moderate type Inflammatory bowel diseases
  • Insensitivity to salicylates
  • Insensitivity to any of the saffron compounds

排除标准

  • Reluctance to continue participating in the study
  • Death of the patient
  • Pregnancy or breastfeeding
  • In case of any unwanted side effects

研究者

发起方
Shahre-kord University of Medical Sciences

相似试验

进行中(未招募)
不适用
Evaluation of the role of mesalazine in the treatment of diverticular disease of the colon and irritable colon syndrome: A randomised double blind placebo controlled clinical study - NDIrritable bowel Syndrome Diverticular disease of the colonMedDRA version: 9.1Level: LLTClassification code 10009993MedDRA version: 9.1Level: LLTClassification code 10023004
EUCTR2008-004228-22-ITSOFAR SPA
已完成
不适用
Treatment of abdominal symptoms in non-complicateddiverticulosis.Diverticular disease of intestine, Diverticular disease of large intestine without perforation or abscess, Diverticular disease of both small and large intestine without perforation or abscess, Diverticular disease of intestine, part unspecified, withoutk57.3, k57
IRCT201606237080N4Vice Chancellor for research of Babol University of Medical Sciences120
进行中(未招募)
1 期
Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D). - Mesalazine for the treatment of IBS-DDiarrhoea-predominant irritable bowel syndromeMedDRA version: 14.0 Level: LLT Classification code 10060849 Term: Diarrhoea predominant irritable bowel syndrome System Organ Class: 10017947 - Gastrointestinal disorders
EUCTR2010-018340-14-GBniversity of Nottingham136
已完成
2 期
Mesalazine in chronic idiopathic urticariaChronic Idiopathic urticaria.Idiopathic Urticaria
IRCT138710041520N1Shiraz University of Medical Sciences - Vice Chancellor for Research Affairs30
招募中
不适用
In-vivo Bioequivalence study of Mezasa granules with brand drugs (PENTASA Ferring Pharmaceuticals Co, Gremany)Bio equivalence test.
IRCT20200105046010N40Koushan Pharmed Pharmaceutical Company24